Skip to main content
Improve  Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,954 across all filing types
Latest filing 2017-04-27 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
2017年面向合格投资者公开发行创新创业公司债券(第一期)票面利率公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the coupon rate (票面利率公告) for a bond issuance by Guangzhou Yangpu Medical Technology Co., Ltd. It details the approval by the China Securities Regulatory Commission, the bond issuance scale, the interest rate inquiry process, and the final coupon rate determination. The document is short (1111 characters) and focuses on financing activity related to bond issuance, specifically the coupon rate announcement. It is not a full financial report, audit, or earnings release, nor is it a regulatory filing or report publication announcement. The content fits best under Capital/Financing Update (CAP) as it provides an update on the company's financing activity and bond issuance terms.
2017-04-27 Chinese
2017年第一季度报告全文
Interim / Quarterly Report Classification · 95% confidence The document is titled "广州阳普医疗科技股份有限公司 2017 年第一季度报告" which translates to "Guangzhou Yangpu Medical Technology Co., Ltd. 2017 First Quarter Report." It contains detailed financial data including income, profit, cash flow, assets, liabilities, and equity for the first quarter of 2017. It also includes management discussion on business risks, operational performance, and strategic outlook. The presence of quarterly financial statements and comprehensive analysis indicates this is a quarterly financial report. The document length is about 15,000 characters, which is consistent with a full interim/quarterly report rather than a brief announcement or summary. There is no indication that this is an announcement of a report or a certification letter. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2017
2017-04-26 Chinese
独立董事候选人声明(陈菁佩)
Regulatory Filings Classification · 95% confidence The document is a formal declaration by an independent director candidate of Guangzhou Yangpu Medical Technology Co., Ltd. It contains detailed statements confirming the candidate's qualifications and compliance with relevant laws and regulations for serving as an independent director. There are no financial statements, earnings data, or report summaries. The document is a regulatory compliance statement related to board/management qualifications rather than an announcement of board changes or a management report. It is not a full report or financial filing but a formal declaration related to governance and director candidacy. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a compliance document that does not fit other specific categories.
2017-04-26 Chinese
独立董事关于公司董事会换届选举暨第四届董事会董事候选人提名的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding the nomination of candidates for the company's board of directors for the fourth board term. It discusses the nomination process, qualifications, and independence of the candidates, referencing relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and nominations. The document length is short (1125 characters), and it is not an announcement of a report but an opinion related to board nominations. Therefore, the most appropriate classification is Board/Management Information (MANG).
2017-04-26 Chinese
第三届监事会第三十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 31st meeting of the third Supervisory Board of Guangzhou Yangpu Medical Technology Co., Ltd. It includes approval of the company's 2017 first quarter report and the nomination of candidates for the fourth Supervisory Board. The document does not contain the full quarterly report itself but references it and states it is available on the official disclosure website. The document also includes details about the candidates for the Supervisory Board and voting results. Given the document length (1770 characters) and content, it is an announcement of meeting resolutions and candidate nominations rather than the full interim/quarterly report or a management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes in company board or senior management, including supervisory board elections and meeting resolutions.
2017-04-26 Chinese
独立董事提名人声明(三)
Board/Management Information Classification · 95% confidence The document is a public statement from the board of Guangzhou Yangpu Medical Technology Co., Ltd. nominating an independent director candidate. It details the qualifications, compliance with laws and regulations, and independence criteria of the nominee. There is no financial data, no report or results announcement, and no mention of voting results or meeting materials. This is an announcement related to board/management changes, specifically the nomination of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is 3231 characters, which is consistent with a detailed announcement rather than a full report.
2017-04-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.